302 related articles for article (PubMed ID: 31132668)
1. Thalidomide ameliorates rosacea-like skin inflammation and suppresses NF-κB activation in keratinocytes.
Chen M; Xie H; Chen Z; Xu S; Wang B; Peng Q; Sha K; Xiao W; Liu T; Zhang Y; Li J; Deng Z
Biomed Pharmacother; 2019 Aug; 116():109011. PubMed ID: 31132668
[TBL] [Abstract][Full Text] [Related]
2. Aspirin alleviates skin inflammation and angiogenesis in rosacea.
Deng Z; Xu S; Peng Q; Sha K; Xiao W; Liu T; Zhang Y; Wang B; Xie H; Chen M; Li J
Int Immunopharmacol; 2021 Jun; 95():107558. PubMed ID: 33743316
[TBL] [Abstract][Full Text] [Related]
3. Artemisinin, a potential option to inhibit inflammation and angiogenesis in rosacea.
Yuan X; Li J; Li Y; Deng Z; Zhou L; Long J; Tang Y; Zuo Z; Zhang Y; Xie H
Biomed Pharmacother; 2019 Sep; 117():109181. PubMed ID: 31387196
[TBL] [Abstract][Full Text] [Related]
4. Targeting Aquaporin-3 Attenuates Skin Inflammation in Rosacea.
Chen M; Peng Q; Tan Z; Xu S; Wang Y; Wu A; Xiao W; Wang Q; Xie H; Li J; Shi W; Deng Z
Int J Biol Sci; 2023; 19(16):5160-5173. PubMed ID: 37928265
[TBL] [Abstract][Full Text] [Related]
5. Celastrol inhibits LL37-induced rosacea by inhibiting Ca
Zeng Q; Yang J; Yan G; Zhang L; Wang P; Zhang H; Chen Q; Cao Y; Liu X; Wang X
Biomed Pharmacother; 2022 Sep; 153():113292. PubMed ID: 35717785
[TBL] [Abstract][Full Text] [Related]
6. Tranexamic acid ameliorates rosacea symptoms through regulating immune response and angiogenesis.
Li Y; Xie H; Deng Z; Wang B; Tang Y; Zhao Z; Yuan X; Zuo Z; Xu S; Zhang Y; Li J
Int Immunopharmacol; 2019 Feb; 67():326-334. PubMed ID: 30578968
[TBL] [Abstract][Full Text] [Related]
7. Dietary supplementation of n-3 PUFAs ameliorates LL37-induced rosacea-like skin inflammation via inhibition of TLR2/MyD88/NF-κB pathway.
Shen S; Yan G; Cao Y; Zeng Q; Zhao J; Wang X; Wang P
Biomed Pharmacother; 2023 Jan; 157():114091. PubMed ID: 36481403
[TBL] [Abstract][Full Text] [Related]
8. A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages.
Zhang J; Jiang P; Sheng L; Liu Y; Liu Y; Li M; Tao M; Hu L; Wang X; Yang Y; Xu Y; Liu W
Front Immunol; 2021; 12():609615. PubMed ID: 34322115
[TBL] [Abstract][Full Text] [Related]
9. Formula PSORI-CM01 inhibits the inflammatory cytokine and chemokine release in keratinocytes via NF-κB expression.
Han L; Sun J; Lu CJ; Zhao RZ; Lu Y; Lin HJ; Wei JA
Int Immunopharmacol; 2017 Mar; 44():226-233. PubMed ID: 28129604
[TBL] [Abstract][Full Text] [Related]
10. Facile skin targeting of a thalidomide analog containing benzyl chloride moiety alleviates experimental psoriasis via the suppression of MAPK/NF-κB/AP-1 phosphorylation in keratinocytes.
Tang KW; Lin ZC; Wang PW; Alalaiwe A; Tseng CH; Fang JY
J Dermatol Sci; 2020 Aug; 99(2):90-99. PubMed ID: 32622642
[TBL] [Abstract][Full Text] [Related]
11. A positive feedback loop between mTORC1 and cathelicidin promotes skin inflammation in rosacea.
Deng Z; Chen M; Liu Y; Xu S; Ouyang Y; Shi W; Jian D; Wang B; Liu F; Li J; Shi Q; Peng Q; Sha K; Xiao W; Liu T; Zhang Y; Zhang H; Wang Q; Sun L; Xie H; Li J
EMBO Mol Med; 2021 May; 13(5):e13560. PubMed ID: 33734592
[TBL] [Abstract][Full Text] [Related]
12. Exploring metformin as a candidate drug for rosacea through network pharmacology and experimental validation.
Li Y; Yang L; Wang Y; Deng Z; Xu S; Xie H; Zhang Y; Li J
Pharmacol Res; 2021 Dec; 174():105971. PubMed ID: 34763093
[TBL] [Abstract][Full Text] [Related]
13. Alarmin function of cathelicidin antimicrobial peptide LL37 through IL-36γ induction in human epidermal keratinocytes.
Li N; Yamasaki K; Saito R; Fukushi-Takahashi S; Shimada-Omori R; Asano M; Aiba S
J Immunol; 2014 Nov; 193(10):5140-8. PubMed ID: 25305315
[TBL] [Abstract][Full Text] [Related]
14. Colchicine Alleviates Rosacea by Inhibiting Neutrophil Inflammation Activated by the TLR2 Pathway.
Yuan X; Sheng L; Shi G; Jiang L; Lian C
Inflammation; 2024 Jun; 47(3):1002-1014. PubMed ID: 38279067
[TBL] [Abstract][Full Text] [Related]
15. Gomisin M2 alleviates psoriasis‑like skin inflammation by inhibiting inflammatory signaling pathways.
Kim N; Lee S; Kang J; Kwon TK; Khang D; Kim SH
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34664681
[TBL] [Abstract][Full Text] [Related]
16. Protectin D1 reduces imiquimod-induced psoriasiform skin inflammation.
Park KD; Kim N; Kang J; Dhakal H; Kim JY; Jang YH; Lee WJ; Lee SJ; Kim SH
Int Immunopharmacol; 2021 Sep; 98():107883. PubMed ID: 34153674
[TBL] [Abstract][Full Text] [Related]
17. Recombinant erythroid differentiation regulator 1 inhibits both inflammation and angiogenesis in a mouse model of rosacea.
Kim M; Kim KE; Jung HY; Jo H; Jeong SW; Lee J; Kim CH; Kim H; Cho D; Park HJ
Exp Dermatol; 2015 Sep; 24(9):680-5. PubMed ID: 25940661
[TBL] [Abstract][Full Text] [Related]
18. Activation of aryl hydrocarbon receptor ameliorates rosacea-like eruptions in mice and suppresses the TLR signaling pathway in LL-37-induced HaCaT cells.
Sun Y; Chen L; Wang H; Zhu P; Jiang S; Qi R; Wu Y; Gao X
Toxicol Appl Pharmacol; 2022 Sep; 451():116189. PubMed ID: 35926563
[TBL] [Abstract][Full Text] [Related]
19. Khasianine ameliorates psoriasis-like skin inflammation and represses TNF-α/NF-κB axis mediated transactivation of IL-17A and IL-33 in keratinocytes.
Yang Y; Zhang Y; Chen X; Su Z; Deng Y; Zhao Q
J Ethnopharmacol; 2022 Jun; 292():115124. PubMed ID: 35183690
[TBL] [Abstract][Full Text] [Related]
20. Thalidomide Improves Psoriasis-like Lesions and Inhibits Cutaneous VEGF Expression without Alteration of Microvessel Density in Imiquimod- induced Psoriatic Mouse Model.
Liu JH; Wu HH; Zhao YK; Wang F; Gao Q; Luo DQ
Curr Vasc Pharmacol; 2018; 16(5):510-521. PubMed ID: 28982338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
